Teresa Mattarelli
Corporate Officer/Principal en Perspectum Group Ltd. .
Cargos activos de Teresa Mattarelli
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01/02/2021 | - |
Historial de carrera de Teresa Mattarelli
Antiguos cargos conocidos de Teresa Mattarelli.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MEDTRONIC PLC | Corporate Officer/Principal | 01/01/2016 | 01/11/2020 |
Formación de Teresa Mattarelli.
McGill University | Masters Business Admin |
Estadísticas
Internacional
Reino Unido | 2 |
Canadá | 2 |
Irlanda | 2 |
Operativa
Corporate Officer/Principal | 2 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectorial
Technology Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
MEDTRONIC PLC | Health Technology |
Empresas privadas | 1 |
---|---|
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Technology Services |
- Bolsa de valores
- Insiders
- Teresa Mattarelli
- Experiencia